Member Article

The advancement of immuno-oncology

The use of immunotherapy products to help counter cancer is one of the latest innovations in the field of oncological technology. Clinical trials of these products have shown a paradigm shift in the increase in the survival of cancer patients.

Although still in its infancy stage, the trials conducted have furnished favourable outcomes with respect to longevitiy and building of immunity of cancer patients. Therefore, further R&D of similar immuno-oncology therapies is in the pipeline.

This whitepaper on immuno-oncology http://www.researchpartnership.com/news/2015/11/free-thinking-from-promise-to-practice-immuno-oncology-in-action/ serves to provide an overview of the medical research taking place in this domain. It focusses on the finanical feasibility and technological progress of the immunotherapy products. Deeper insights regarding the practical applicability of these products in the US as well as the EU have also been explored after taking inputs from significant opinion leaders and experts in the pharmaceutical and healthcare market research field.

This was posted in Bdaily's Members' News section by Steve James .